Tag: Biologics

A new special issue in Frontiers in Pediatrics gathers ten peer-reviewed studies revealing how inflammatory bowel disease presents, is diagnosed, ...

Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.

A large real-world study of Medicare beneficiaries found mepolizumab matched dupilumab for preventing asthma hospitalizations and significantly reduced exacerbation rates, ...

A 16-year analysis of 361 overseas new drugs shows China's regulatory reforms cut approval lag and reimbursement delays, but biologics, ...

A two-year Japanese real-world study of 66 patients shows the dual IL-17A and IL-17F inhibitor bimekizumab sustained high clearance rates ...

A new case series and literature review suggest the interleukin-4 and interleukin-13 blocker dupilumab may bring relief to patients with ...

A new narrative review repositions methotrexate as a complementary, steroid-sparing option in Still's disease while confirming that early interleukin-1 or ...

A new systematic review finds that phosphodiesterase-4 inhibitors achieved clinical response in 53.4 percent of hidradenitis suppurativa patients with a ...

Spanish researchers have developed a humanized monoclonal antibody, hB101.37, that inhibits the BAMBI pseudoreceptor and rebalances T cell immunity, showing ...

A systematic review of 44 studies finds myasthenia gravis costs societies thousands of euros per patient annually, with indirect and ...

Researchers chemically hollowed out microscopic silica needles from marine sponges, creating natural microneedle channels that delivered proteins, antibody fragments, and ...

A Belgian qualitative study of patients, gastroenterologists, and IBD nurses reveals a persistent gap between clinicians' belief that they practice ...

In recent years, the field of regenerative medicine has made significant strides, particularly in the utilization of biologics derived from ...